| GAHPX | VEMAX | GAHPX / VEMAX | |
| Total Expense Ratio | 1.02 | 0.13 | 785% |
| Annual Report Gross Expense Ratio | 1.11 | 0.13 | 854% |
| Fund Existence | 8 years | 20 years | - |
| Gain YTD | 26.086 | 14.130 | 185% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.35B | 168B | 2% |
| Annual Yield % from dividends | 0.63 | 2.24 | 28% |
| Returns for 1 year | 41.22 | 21.35 | 193% |
| Returns for 3 years | 87.20 | 59.60 | 146% |
| Returns for 5 years | 24.63 | 28.70 | 86% |
| Returns for 10 years | N/A | 87.28 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WMMAX | 17.10 | 0.27 | +1.60% |
| TETON Westwood Mighty Mites A | |||
| SCSAX | 19.18 | 0.08 | +0.42% |
| Allspring Common Stock A | |||
| WFGGX | 35.57 | -0.01 | -0.03% |
| First Trust WCM Focused Global Gr Inv | |||
| JSCGX | 24.11 | -0.08 | -0.33% |
| Jacob Small Cap Growth Investor | |||
| SHSCX | 48.57 | -0.47 | -0.96% |
| BlackRock Health Sciences Opps Inv C | |||